| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An evaluation of the NCI Physician Data Query (PDQ) dissemination in Europe
|
Arrigo, C.
|
|
1997
|
33 |
7 |
p. 997-1001
5 p.
|
artikel
|
| 2 |
Antiproliferative effects of paclitaxel (Taxol®) on human renal clear cell carcinomas in vitro
|
Reinecke, P.
|
|
1997
|
33 |
7 |
p. 1122-1129
8 p.
|
artikel
|
| 3 |
A phase II study of continuous infusional 5-fluorouracil (5-FU) and subcutaneous interleukin-2 (IL-2) in metastatic renal cancer
|
Savage, P.
|
|
1997
|
33 |
7 |
p. 1149-1151
3 p.
|
artikel
|
| 4 |
Aromatase inhibitors for breast cancer—further progress
|
Rubens, R.D.
|
|
1997
|
33 |
7 |
p. 989-990
2 p.
|
artikel
|
| 5 |
Breast cancer risk revealed by K:Na ratio of cyst fluid
|
|
|
1997
|
33 |
7 |
p. 984-
1 p.
|
artikel
|
| 6 |
Calendar of forthcoming meetings
|
|
|
1997
|
33 |
7 |
p. I-III
nvt p.
|
artikel
|
| 7 |
Cancer burden in Europe for 1990: Can we predict the figures for the year 2000?
|
Coebergh, J.W.W.
|
|
1997
|
33 |
7 |
p. 991-996
6 p.
|
artikel
|
| 8 |
Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990
|
Black, R.J.
|
|
1997
|
33 |
7 |
p. 1075-1107
33 p.
|
artikel
|
| 9 |
Chemo-radiotherapy for locally advanced head and neck cancer—long-term results of a phase II trial
|
Dinges, S.
|
|
1997
|
33 |
7 |
p. 1152-1155
4 p.
|
artikel
|
| 10 |
Clinical and immunomodulatory effects of repetitive 2-day cycles of high-dose continuous infusion IL-2
|
Engelhardt, M.
|
|
1997
|
33 |
7 |
p. 1050-1054
5 p.
|
artikel
|
| 11 |
Dr Bernard Fisher exonerated by office of research integrity
|
|
|
1997
|
33 |
7 |
p. 981-
1 p.
|
artikel
|
| 12 |
EONS distinguished merit award goes to Dr Agnes Glaus
|
|
|
1997
|
33 |
7 |
p. 985-
1 p.
|
artikel
|
| 13 |
EORTC Board for 1997–2000
|
|
|
1997
|
33 |
7 |
p. 982-
1 p.
|
artikel
|
| 14 |
Evidence based medicine, a new challenge
|
Costa, A.
|
|
1997
|
33 |
7 |
p. 987-988
2 p.
|
artikel
|
| 15 |
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90)
|
Thürlimann, B.
|
|
1997
|
33 |
7 |
p. 1017-1024
8 p.
|
artikel
|
| 16 |
Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II
|
Jungwirth, A.
|
|
1997
|
33 |
7 |
p. 1141-1148
8 p.
|
artikel
|
| 17 |
Interferon gamma induces cell cycle arrest and apoptosis in a model of ovarian cancer: Enhancement of effect by batimastat
|
Burke, F.
|
|
1997
|
33 |
7 |
p. 1114-1121
8 p.
|
artikel
|
| 18 |
Letters to the editor: Comments on swiss plan to fight against breast cancer, international cancer news, Eur j cancer, 32A, No. 11, pp. 1830–1831, 1996
|
Weisburger, J.H.
|
|
1997
|
33 |
7 |
p. 1156-
1 p.
|
artikel
|
| 19 |
Long-term results from the first UKCCSG Ewing's tumour study (ET-1)
|
Craft, A.W.
|
|
1997
|
33 |
7 |
p. 1061-1069
9 p.
|
artikel
|
| 20 |
NCI statement on genetic testing for cancer risk
|
|
|
1997
|
33 |
7 |
p. 981-
1 p.
|
artikel
|
| 21 |
New cochrane collaborative review groups under development
|
|
|
1997
|
33 |
7 |
p. 983-
1 p.
|
artikel
|
| 22 |
Pofessor E. van der Schueren apointed as Director of Medical Affairs, University Hospital, Gasthuisberg, Leuven
|
|
|
1997
|
33 |
7 |
p. 985-
1 p.
|
artikel
|
| 23 |
polyethylene glycol conjugated insulin-like growth factor binding protein-1 (IGFBP-1) inhibits growth of breast cancer in athymic mice
|
Van Den Berg, C.L.
|
|
1997
|
33 |
7 |
p. 1108-1113
6 p.
|
artikel
|
| 24 |
Portal vein infusion saves 5%
|
|
|
1997
|
33 |
7 |
p. 984-
1 p.
|
artikel
|
| 25 |
Primary treatment in stage II non-seminomatous germ cell tumours of the testis: a Matter of scalpel or drug infusion?
|
Sandeman, T.F.
|
|
1997
|
33 |
7 |
p. 1157-1158
2 p.
|
artikel
|
| 26 |
Prognostic factors for neutropenic patients in an intensive care unit: Respective roles of underlying malignancies and acute organ failures
|
Blot, F.
|
|
1997
|
33 |
7 |
p. 1031-1037
7 p.
|
artikel
|
| 27 |
Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy
|
Coates, A.
|
|
1997
|
33 |
7 |
p. 1025-1030
6 p.
|
artikel
|
| 28 |
Regulation of the eukaryotic cell cycle
|
Nurse, P.
|
|
1997
|
33 |
7 |
p. 1002-1004
3 p.
|
artikel
|
| 29 |
Response from: I. Rajower, A.J. Sasco and P. Kleihues
|
Rajower, I.
|
|
1997
|
33 |
7 |
p. 1157-
1 p.
|
artikel
|
| 30 |
Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer
|
Klepp, O.
|
|
1997
|
33 |
7 |
p. 1038-1044
7 p.
|
artikel
|
| 31 |
Risk factors for colorectal cancer same in those with and without family history
|
|
|
1997
|
33 |
7 |
p. 983-
1 p.
|
artikel
|
| 32 |
Roche in 12 billion dollar buy-out
|
|
|
1997
|
33 |
7 |
p. 983-
1 p.
|
artikel
|
| 33 |
The effect of onapristone, a progesterone antagonist, on the growth of human gastrointestinal cancer xenografts
|
Jacobs, E.
|
|
1997
|
33 |
7 |
p. 1130-1135
6 p.
|
artikel
|
| 34 |
The role of radiotherapy in the local management of dermatofibrosarcoma protuberans
|
Haas, R.L.M.
|
|
1997
|
33 |
7 |
p. 1055-1060
6 p.
|
artikel
|
| 35 |
The role of the bystander effect in suicide gene therapy
|
Pope, I.M.
|
|
1997
|
33 |
7 |
p. 1005-1016
12 p.
|
artikel
|
| 36 |
The use of a systemic therapy checklist improves the quality of data acquisition and recording in multicentre trials. A study of the EORTC soft tissue and bone sarcoma group
|
Verweij, J.
|
|
1997
|
33 |
7 |
p. 1045-1049
5 p.
|
artikel
|
| 37 |
The use of SCID mice for the growth of retinoblastoma cell lines and for the establishment of xenografts from primary tumours
|
Cowell, J.K.
|
|
1997
|
33 |
7 |
p. 1070-1074
5 p.
|
artikel
|
| 38 |
TP53 mutations in stage I gallbladder carcinoma with special attention to growth patterns
|
Hanada, K.
|
|
1997
|
33 |
7 |
p. 1136-1140
5 p.
|
artikel
|
Tijdschrift beschrijving